Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
What does Taiwan mean to China? 2024-11-29 22:00
Minghui Pharmaceutical Announces Positive Topline Results from Phase Ⅲ Trial of MH004 (Tofacitinib Etocomil) Ointment in Mild to Moderate Atopic Dermatitis 2024-11-29 20:31
Life-Space Wins Prestigious 62nd Australian Export Awards 2024-11-29 16:00
"Are your Hands & Feet trying to tell you something?" - Ask leading Health Experts 2024-11-29 13:30
2024 Global Youth Powerhouse Summit in Hong Kong: Global Leaders and Young Professionals Address Innovation and Economic Development 2024-11-29 13:02
Ping An Wins Sixth Director of the Year Award and Inaugural Climate Governance Award from the Hong Kong Institute of Directors 2024-11-29 10:56
Akeso to Present at Citi 2024 Global Healthcare Conference and the 7th Annual Evercore HealthCONx Conference 2024-11-29 10:23
Borsch Med Partners with Unity Pharmacies to Help Elderly Access Zeria Chondroitin-based Joint Health Supplements in Support of Healthy Ageing in Singapore 2024-11-29 10:00
Microbio Appoints Paul Brennan as Chair of the Board 2024-11-29 06:30
Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline 2024-11-28 21:30
Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline 2024-11-28 21:06
First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients 2024-11-28 17:22
Global Times: Atoms for a better home: CNNC showcases 'Chinese solution' on nuclear technology application to the world 2024-11-28 17:04
New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List 2024-11-28 16:59
Own Your Story with AwarerHOME™ 2024-11-28 16:34
Everest Medicines Announces NEFECON®, the World's First Approved Treatment for IgA Nephropathy, is Included in China's National Reimbursement Drug List 2024-11-28 13:43
Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country 2024-11-28 13:04
Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China's National Reimbursement Drug List 2024-11-28 12:07
Akeso Announced the Inclusion in China's National Reimbursement Drug List of Cadonilimab and Ivonescimab 2024-11-28 11:58
Dr. Robert Yap Honoured with World Chinese Distinguished Entrepreneur Lifetime Achievement Award at GCET 2024 2024-11-28 10:39
1 12 13 14 15 16 1612